Laura Obici

24PUBLICATIONS
110CO-AUTHORS
Gene and molecular therapyNutritional epidemiologyCardiology (incl. cardiovascular diseases)Tissue engineeringAvionics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (24)

|Jul 09, 2026
Guidelines for the management of hereditary ATTR amyloidosis 2026.

|Jun 15, 2026
Long-term efficacy and safety of vutrisiran in hereditary transthyretin amyloidosis with polyneuropathy: final analysis of the HELIOS-A randomized treatment extension.

|May 30, 2026
Baseline characteristics of patients with transthyretin amyloidosis with cardiomyopathy in the CARDIO-TTRansform trial of eplontersen.

|May 30, 2026
Outpatient worsening heart failure in transthyretin amyloid cardiomyopathy: Findings from ATTRibute-CM.

|May 09, 2026
Rationale and Design of CARDIO-TTRansform, a Phase 3 Trial of Eplontersen in Transthyretin Amyloid Cardiomyopathy.

|Apr 11, 2026
Reply to 'The Illusion of Improvement in ATTR-CM: Re-evaluating Informative Missingness and Discordant Endpoints in ATTRibute-CM'.

Francesco Cappelli, Marianna Fontana, Pablo Garcia-Pavia

Pageof 4

Frequent Collaborators

8 joint publications

Julian Gillmore

7 joint publications

Pablo Garcia-Pavia

6 joint publications

Ahmad Masri

5 joint publications

Marianna Fontana